Weight Loss Injections in 2026: Every Option, What It Costs & How to Get One
Zepbound, Wegovy, the new GLP-1 pills, Saxenda, compounded shots, "skinny shots"... the options multiplied fast. This guide sorts what's FDA-approved from what isn't, shows who qualifies and how much weight people actually lost, and finds the cheapest legitimate way to pay for your situation.
Medically reviewed Medically reviewed by Angelo DeFazio, R.Ph. — NPI 1629115530 · Last updated 2026-11-13
The FDA-approved weight loss injections are Zepbound and Wegovy (weekly) and Saxenda (daily), plus two pills, the Wegovy pill and Foundayo. They're for adults with a BMI of 30+, or 27+ with a weight-related condition. Zepbound produced the most weight loss in trials (about 21%). Without insurance, cash prices run $149–$449 a month; with Medicare, eligible members pay $50 through the GLP-1 Bridge. "Skinny shots" with B12 or HCG are not approved for weight loss.
Find your options and price
Answer five questions. We'll show which FDA-approved options your situation fits under their labels, and the cheapest way to pay for each. Nothing you enter leaves your browser.
| Medicine | Form | Ages | Average weight loss (FDA trial) | Cash price | Medicare $50 Bridge |
|---|---|---|---|---|---|
| Zepboundtirzepatide | Weekly injection | 18+ | 20.9% at 15 mg (72 weeks) | $299–$449/month (KwikPen or vials, LillyDirect self-pay) | Yes, if eligible |
| Wegovy pensemaglutide | Weekly injection | 12+ | 14.9% at 2.4 mg (68 weeks); 18.8% at 7.2 mg Wegovy HD (72 weeks) | $199/month for the first 2 months, then $349 ($399 for 7.2 mg HD) | Yes, if eligible |
| Wegovy pillsemaglutide | Daily tablet | 18+ | 13.6% at 25 mg (64 weeks, OASIS 4) | $149–$299/month | Yes, if eligible |
| Foundayoorforglipron | Daily tablet | 18+ | 11.1% at 17.2 mg (72 weeks) | $149–$349/month | Yes, if eligible |
| Saxenda or generic liraglutideliraglutide 3 mg | Daily injection | 12+ | 7.4% vs. 3.0% on placebo (56 weeks) | Generic exists, but pharmacies pay about $709/month for it (NADAC), so cash prices are usually higher than the newer drugs | No |
Every FDA-approved option
Every approved weight-loss medicine in this group copies one or two gut hormones that tell the brain you're full and slow stomach emptying. They differ in molecule, how often you take them and how much they do:
Zepbound
- Molecule
- Tirzepatide (GIP + GLP-1)
- Approved for
- Weight loss; sleep apnea with obesity
- Ages
- Adults
- Forms
- Single-dose pens, KwikPen, vials
Wegovy
- Molecule
- Semaglutide (GLP-1)
- Approved for
- Weight loss; lowering heart-attack and stroke risk; MASH liver disease
- Ages
- 12 and older
- Forms
- Pens up to 2.4 mg, plus 7.2 mg Wegovy HD
Saxenda / generic liraglutide
- Molecule
- Liraglutide 3 mg (GLP-1)
- Approved for
- Weight loss
- Ages
- 12 and older (over 60 kg)
- Forms
- Daily pen; generics since 2025
Wegovy pill · Foundayo
- Molecule
- Semaglutide · orforglipron
- Approved for
- Weight loss (Wegovy pill also heart risk)
- Ages
- Adults
- Difference
- Wegovy pill: empty stomach, 30 min before food. Foundayo: any time, no food rules
Not on this list: Ozempic and Mounjaro. They contain the same molecules as Wegovy and Zepbound but are approved for type 2 diabetes, and prescribing them for weight loss is off-label, which insurers rarely cover. See Ozempic vs. Mounjaro vs. Wegovy vs. Zepbound. Older weight-loss pills such as phentermine are a different, non-GLP-1 class.
How much weight people lose
Sources: FDA labels for Zepbound, Wegovy, Foundayo and Saxenda; Wegovy pill from Novo Nordisk's OASIS 4 trial. Saxenda's placebo group lost 3.0%. Different trials and populations, so treat this as a rough guide, not a head-to-head result.
On a 230-pound person, Zepbound's average result is about 48 pounds and Saxenda's about 17. The medicine you can actually get and afford usually matters more than the ranking.
In the trials, weight loss continued for roughly the first year and then leveled off. The labels describe these medicines as long-term treatment to reduce weight and keep it off, alongside a reduced-calorie diet and more activity.
Who qualifies
Adults
- BMI 30 or more (obesity), or
- BMI 27 or more with at least one weight-related condition: high blood pressure, high cholesterol, prediabetes or type 2 diabetes, sleep apnea, heart disease
Teens 12–17
- Wegovy pen or Saxenda only
- Obesity by BMI-for-age (95th percentile or higher)
- Saxenda: body weight over 60 kg (132 lb)
Stricter BMI rules
- BMI 35+, or
- 30+ with heart failure with preserved ejection fraction, uncontrolled high blood pressure or stage 3a+ kidney disease, or
- 27+ with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease
Who shouldn't take them: anyone with a personal or family history of medullary thyroid cancer or MEN 2 (all carry this boxed warning), and anyone pregnant. Commercial insurers often add their own requirements, such as documented diet attempts. Details by insurer are in our GLP-1 insurance guide, which also builds an appeal letter if you're denied.
How to get a weight loss injection
- See a prescriber.Your primary care provider, an obesity-medicine specialist, or a licensed telehealth service. Bring your weight history, conditions and current medicines.
- Check coverage before choosing.Ask your plan which weight-loss drug it prefers and whether it needs prior authorization. That often decides between Zepbound and Wegovy.
- Prior authorization, if needed.Your prescriber submits it; approvals can take days. Medicare Bridge requests go to CMS.
- Send the prescription to your pharmacy.Including a telehealth prescription: you can pick where it's filled.
- Start low and step up.Every product starts at a low dose and increases about monthly to limit nausea. Our dose schedule calculator maps each step and refill date.
- Refill on time.Missing doses can mean restarting at a lower dose, and some cash prices depend on refilling within a set window.
What it costs
Sources: Lilly and Novo Nordisk self-pay terms, Medicare GLP-1 Bridge fact sheet, CMS NADAC (October 21, 2026) for liraglutide 18 mg/3 mL 5-pack at $47.27/mL × 15 mL. Your price depends on coverage and dose.
The generic surprise. Saxenda went generic in 2025, but a month of generic liraglutide (five pens) still costs pharmacies about $709, against $1,306 for brand Saxenda (NADAC, October 2026). That's more than the cash price of Wegovy or Zepbound, for less weight loss. It mainly makes sense when your plan covers it and not the newer drugs.
Full price tables by dose, insurance and HUSKY rules are in our GLP-1 cost guide, and every savings card is compared in GLP-1 savings cards and coupons.
Side effects and safety
| Side effect (label) | Zepbound 5–15 mg | Wegovy 2.4 mg | Foundayo 5.5–17.2 mg | Saxenda 3 mg |
|---|---|---|---|---|
| Nausea | 25–29% (placebo 8%) | 44% (16%) | 26–35% (10%) | 39% (14%) |
| Diarrhea | 19–23% (8%) | 30% (16%) | 21–25% (11%) | 21% (10%) |
| Vomiting | 8–13% (2%) | 24% (6%) | 13–24% (4%) | 16% (4%) |
| Constipation | 11–17% (5%) | 24% (11%) | 20–27% (9%) | 19% (9%) |
- Boxed warning: thyroid C-cell tumors in rodents. Not for anyone with a personal or family history of medullary thyroid cancer or MEN 2.
- Pancreatitis and gallbladder problems. Get care for severe belly pain that won't go away, with or without vomiting.
- Low blood sugar if you also take insulin or a sulfonylurea; your prescriber may lower those doses.
- Birth control pills. Zepbound and Foundayo can make them less reliable: use a non-oral method or add a barrier method for 4 weeks (Foundayo: 30 days) after starting and after each dose increase.
- Pregnancy. Stop Wegovy at least 2 months before trying to conceive, per its label; tell your prescriber if you plan a pregnancy on any of these.
- Surgery or sedation. Tell the team you take one; food stays in the stomach longer.
- Don't combine two GLP-1 medicines.
Skinny shots, B12, HCG and compounded shots
- Zepbound, Wegovy (pen, HD, pill), Foundayo, Saxenda and generic liraglutide
- Filled by a licensed pharmacy on a prescription, in labeled pens or tablets
- B12 or lipotropic (MIC) "skinny shots": B12 injections are approved for B12 deficiency, not weight loss
- HCG injections: the label itself says HCG hasn't been shown to work for obesity
- Compounded or "research" semaglutide and tirzepatide: not FDA-approved; the shortage allowance ended in 2024–2025
The FDA has reported dosing errors with compounded semaglutide, where people drew up several times the intended dose, and adverse events with unapproved products sold online. With brand cash prices now starting at $149 for pills and $199 for the Wegovy pen, the case for unverified products is much weaker. More detail: compounded tirzepatide and online sellers.
Filling it at Arrow Pharmacy
- We fill Zepbound, Wegovy, the Wegovy pill, Foundayo and liraglutide on any valid prescription, including from telehealth services.
- Covered by your plan? We run the manufacturer savings card with your insurance, which can bring Zepbound or Wegovy to $25.
- Zepbound self-pay KwikPen: that cash card goes through LillyDirect; we can't process it, but we fill covered Zepbound.
- Medicare GLP-1 Bridge: once CMS approves your prescriber's request, call us to confirm we can fill it for $50.
- Help with denials: our appeal letter builder drafts the letter for you.
Call (860) 522-9289 with your prescription and coverage, and we'll check the lowest price before you pay.
Frequently asked questions
What are the weight loss injections called?
The FDA-approved weight-loss injections in 2026 are Zepbound (tirzepatide, weekly), Wegovy (semaglutide, weekly, including the 7.2 mg Wegovy HD dose) and Saxenda (liraglutide, daily, now also sold as a generic). There are also two approved pills: the Wegovy pill and Foundayo (orforglipron). Ozempic and Mounjaro are the diabetes versions of semaglutide and tirzepatide and aren't approved for weight loss.
Which weight loss injection works best?
In their FDA trials, Zepbound 15 mg produced the most average weight loss, 20.9% over 72 weeks, followed by Wegovy HD 7.2 mg (18.8%), Wegovy 2.4 mg (14.9%), the Wegovy pill (13.6%), Foundayo (11.1%) and Saxenda (7.4%). These were different trials, so the numbers aren't a head-to-head comparison, and individual results vary a lot.
Who qualifies for weight loss injections?
Under the FDA labels, adults with obesity (generally a BMI of 30 or more) or overweight (BMI 27 or more) with at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes or sleep apnea. Wegovy and Saxenda are also approved for teens 12 and older with obesity by BMI-for-age. Insurance and Medicare have their own, sometimes stricter, rules.
How much do weight loss injections cost without insurance?
Manufacturer cash prices in November 2026: the Wegovy pen is $199 a month for the first two months, then $349 ($399 for 7.2 mg); Zepbound is $299 to $449 a month; the Wegovy pill and Foundayo start at $149. Generic liraglutide (Saxenda) costs pharmacies about $709 a month, so it is usually not the cheap option it sounds like.
Does Medicare cover weight loss injections?
From July 1, 2026 to December 31, 2027, the Medicare GLP-1 Bridge covers Wegovy (pen or pill), the Zepbound KwikPen and Foundayo for $50 a month if you qualify: a BMI of 35 or more, or 30 or more with heart failure with preserved ejection fraction, uncontrolled high blood pressure or stage 3a+ kidney disease, or 27 or more with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease.
Are weight loss injections safe?
They are FDA-approved with known risks. Nausea, diarrhea, vomiting and constipation are common, mostly while the dose is going up. All carry a boxed warning about thyroid C-cell tumors seen in rodents, so they aren't used with a personal or family history of medullary thyroid cancer or MEN 2. Pancreatitis, gallbladder problems and low blood sugar with insulin or sulfonylureas are less common risks.
Do B12 or lipotropic "skinny shots" work for weight loss?
There is no FDA-approved B12, lipotropic (MIC) or "fat-burning" injection for weight loss. Vitamin B12 injections are approved to treat B12 deficiency. HCG injections carry a label statement that HCG has not been shown to work for obesity. Only GLP-1-type medicines are FDA-approved weight-loss injections.
Is compounded semaglutide or tirzepatide legal?
The temporary allowance ended when the FDA declared the semaglutide and tirzepatide shortages over (tirzepatide in December 2024, semaglutide in February 2025). Compounded versions are not FDA-approved generics, and the FDA has received reports of dosing errors and adverse events. With brand cash prices now from $149 to $449, the savings are much smaller than they were.
Can I get weight loss injections online?
Yes, through a licensed telehealth prescriber who reviews your history and sends a prescription to a pharmacy. You can choose to fill it at a local pharmacy such as Arrow. Be wary of sites that sell injections without a prescription or ship unlabeled vials.
Do weight loss injections affect birth control pills?
Zepbound and Foundayo can make birth control pills less reliable. Their labels say to switch to a non-oral method or add a barrier method for 4 weeks (Foundayo: 30 days) after starting and after each dose increase. Wegovy should be stopped at least 2 months before a planned pregnancy.
Sources
- Zepbound (tirzepatide) injection: prescribing information — DailyMed / U.S. National Library of Medicine
- Wegovy (semaglutide) injection and tablets: prescribing information — DailyMed / U.S. National Library of Medicine
- Foundayo (orforglipron) tablets: prescribing information (revised July 2026) — DailyMed / U.S. National Library of Medicine
- Saxenda (liraglutide) injection 3 mg: prescribing information — DailyMed / U.S. National Library of Medicine
- Liraglutide injection (generic of Saxenda, Teva): prescribing information — DailyMed / U.S. National Library of Medicine
- Chorionic gonadotropin (HCG) for injection: prescribing information (statement on obesity) — DailyMed / U.S. National Library of Medicine
- Medicare GLP-1 Bridge: information for providers (clinical eligibility criteria) — Centers for Medicare & Medicaid Services
- Medicare GLP-1 Bridge: GLP-1 drugs for $50 a month (fact sheet) — Medicare.gov (CMS)
- FDA's concerns with unapproved GLP-1 drugs used for weight loss — U.S. Food and Drug Administration
- Foundayo (orforglipron) now available in the U.S. (FDA approval April 1, 2026) — Eli Lilly and Company
- National Average Drug Acquisition Cost (NADAC): Saxenda and liraglutide pens, survey of October 21, 2026 — CMS